For people with type 2 diabetes, drinking more than one alcoholic beverage per day was associated with an increased risk for high blood pressure. (Journal of the American Heart Association)
The phase III LOGICS trial met its primary endpoint, demonstrating that 55% of people with endogenous Cushing’s Syndrome saw a loss of cortisol response after stopping treatment with levoketoconazole (Recorlev), Strongbridge Biopharma announced. The company plans to submit a new drug application to the FDA in early 2021.
Paired with a healthy diet, probiotics may be a helpful aid for children with obesity trying to lose weight. (ScienceDaily)
Young people who experienced weight stigma before the COVID-19 pandemic were at a higher risk for depression or using eating as a coping strategy. (Annals of Behavioral Medicine)
Aeterna Zentaris announced its investigational treatment macimorelin acetate was both safe and well-tolerated in children with suspected growth hormone deficiency.
The American Association of Clinical Endocrinologists (AACE) released a new update to its clinical practice guideline for the treatment of postmenopausal osteoporosis.
In related news, the Endocrine Society and the European Society of Endocrinology announced plans to release a joint global evidence-based clinical practice guideline for various endocrine conditions.
Roger Unger, MD, of the University of Texas Southwestern Medical Center and a leading endocrinologist known for his research on the hormonal mechanisms of diabetes, died at the age of 96. (The Scientist)